🇺🇸 FDA
Patent

US 12252703

Closed-ended linear duplex DNA for non-viral gene transfer

granted A61KA61K48/00A61K48/005

Quick answer

US patent 12252703 (Closed-ended linear duplex DNA for non-viral gene transfer) held by VOYAGER THERAPEUTICS, INC. expires Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.

Key facts

Applicant
VOYAGER THERAPEUTICS, INC.
Grant date
Tue Mar 18 2025 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Mar 13 2045 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
20
CPC classes
A61K, A61K48/00, A61K48/005, A61K48/0075, A61P